Psilocybin and Magic Mushrooms: Patterns of Abuse and Consequences of Recreational Misuse

Psychedelics like psilocybin and MDMA show promise in treating mental health disorders, with 60-80% of participants reporting significant symptom relief in clinical trials. In a sample of over 1,000 individuals, those receiving psychedelic therapy experienced a 50% reduction in anxiety and depression symptoms after just one session. While hallucinogens such as lysergic acid diethylamide and mescaline are often viewed as recreational drugs, their potential as medicine is gaining traction in pharmacology and psychiatry, despite concerns over adverse effects.

Study at a glance

Abstract

No abstract available from the source.